Assessment of patient concern and adequacy of informed consent regarding infertility resulting from prostate cancer treatment

Buffi G. Boyd, Stewart W. McCallum, Ronald W Lewis, Martha Kennedy Terris

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objectives: To address in a questionnaire-based study the frequency at which fertility is a concern for men when they consider their prostate cancer treatment options. A secondary aim was to assess the rate at which men were informed of the fertility implications of prostate cancer treatment by their physician before their selection of a treatment option. Methods: Two questionnaires were used. One questionnaire was distributed to men with localized prostate cancer who had undergone treatment within the past year. These questions addressed whether continence, erectile function, and fertility were discussed with them by their physician during the prostate cancer treatment selection process. The second questionnaire was distributed to men with newly diagnosed prostate cancer and queried their level of concern about the effects of prostate cancer treatment on sexual function, urinary function, and fertility. Results: All patients receiving the first questionnaire stated that they were informed of the incontinence and impotence side effects of prostate cancer treatments, but only 8.7% stated that they were informed of the effect that prostate cancer treatments would have on their future fertility. Of the patients completing the second questionnaire, 53.7% responded that incontinence was the side effect of prostate cancer treatment that caused them the most concern, 42.6% stated that erectile dysfunction was the most concerning, and 3.7% listed fertility as the major concern. Conclusions: Urologists should consider approaching the topic of infertility when discussing the pros and cons of various prostate cancer therapies with their younger patients.

Original languageEnglish (US)
Pages (from-to)840-844
Number of pages5
JournalUrology
Volume68
Issue number4
DOIs
StatePublished - Oct 1 2006

Fingerprint

Informed Consent
Infertility
Prostatic Neoplasms
Fertility
Therapeutics
Erectile Dysfunction
Physicians
Surveys and Questionnaires

ASJC Scopus subject areas

  • Urology

Cite this

Assessment of patient concern and adequacy of informed consent regarding infertility resulting from prostate cancer treatment. / Boyd, Buffi G.; McCallum, Stewart W.; Lewis, Ronald W; Terris, Martha Kennedy.

In: Urology, Vol. 68, No. 4, 01.10.2006, p. 840-844.

Research output: Contribution to journalArticle

@article{5718a4736a324195ad06a0ce77c0b99c,
title = "Assessment of patient concern and adequacy of informed consent regarding infertility resulting from prostate cancer treatment",
abstract = "Objectives: To address in a questionnaire-based study the frequency at which fertility is a concern for men when they consider their prostate cancer treatment options. A secondary aim was to assess the rate at which men were informed of the fertility implications of prostate cancer treatment by their physician before their selection of a treatment option. Methods: Two questionnaires were used. One questionnaire was distributed to men with localized prostate cancer who had undergone treatment within the past year. These questions addressed whether continence, erectile function, and fertility were discussed with them by their physician during the prostate cancer treatment selection process. The second questionnaire was distributed to men with newly diagnosed prostate cancer and queried their level of concern about the effects of prostate cancer treatment on sexual function, urinary function, and fertility. Results: All patients receiving the first questionnaire stated that they were informed of the incontinence and impotence side effects of prostate cancer treatments, but only 8.7{\%} stated that they were informed of the effect that prostate cancer treatments would have on their future fertility. Of the patients completing the second questionnaire, 53.7{\%} responded that incontinence was the side effect of prostate cancer treatment that caused them the most concern, 42.6{\%} stated that erectile dysfunction was the most concerning, and 3.7{\%} listed fertility as the major concern. Conclusions: Urologists should consider approaching the topic of infertility when discussing the pros and cons of various prostate cancer therapies with their younger patients.",
author = "Boyd, {Buffi G.} and McCallum, {Stewart W.} and Lewis, {Ronald W} and Terris, {Martha Kennedy}",
year = "2006",
month = "10",
day = "1",
doi = "10.1016/j.urology.2006.04.009",
language = "English (US)",
volume = "68",
pages = "840--844",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Assessment of patient concern and adequacy of informed consent regarding infertility resulting from prostate cancer treatment

AU - Boyd, Buffi G.

AU - McCallum, Stewart W.

AU - Lewis, Ronald W

AU - Terris, Martha Kennedy

PY - 2006/10/1

Y1 - 2006/10/1

N2 - Objectives: To address in a questionnaire-based study the frequency at which fertility is a concern for men when they consider their prostate cancer treatment options. A secondary aim was to assess the rate at which men were informed of the fertility implications of prostate cancer treatment by their physician before their selection of a treatment option. Methods: Two questionnaires were used. One questionnaire was distributed to men with localized prostate cancer who had undergone treatment within the past year. These questions addressed whether continence, erectile function, and fertility were discussed with them by their physician during the prostate cancer treatment selection process. The second questionnaire was distributed to men with newly diagnosed prostate cancer and queried their level of concern about the effects of prostate cancer treatment on sexual function, urinary function, and fertility. Results: All patients receiving the first questionnaire stated that they were informed of the incontinence and impotence side effects of prostate cancer treatments, but only 8.7% stated that they were informed of the effect that prostate cancer treatments would have on their future fertility. Of the patients completing the second questionnaire, 53.7% responded that incontinence was the side effect of prostate cancer treatment that caused them the most concern, 42.6% stated that erectile dysfunction was the most concerning, and 3.7% listed fertility as the major concern. Conclusions: Urologists should consider approaching the topic of infertility when discussing the pros and cons of various prostate cancer therapies with their younger patients.

AB - Objectives: To address in a questionnaire-based study the frequency at which fertility is a concern for men when they consider their prostate cancer treatment options. A secondary aim was to assess the rate at which men were informed of the fertility implications of prostate cancer treatment by their physician before their selection of a treatment option. Methods: Two questionnaires were used. One questionnaire was distributed to men with localized prostate cancer who had undergone treatment within the past year. These questions addressed whether continence, erectile function, and fertility were discussed with them by their physician during the prostate cancer treatment selection process. The second questionnaire was distributed to men with newly diagnosed prostate cancer and queried their level of concern about the effects of prostate cancer treatment on sexual function, urinary function, and fertility. Results: All patients receiving the first questionnaire stated that they were informed of the incontinence and impotence side effects of prostate cancer treatments, but only 8.7% stated that they were informed of the effect that prostate cancer treatments would have on their future fertility. Of the patients completing the second questionnaire, 53.7% responded that incontinence was the side effect of prostate cancer treatment that caused them the most concern, 42.6% stated that erectile dysfunction was the most concerning, and 3.7% listed fertility as the major concern. Conclusions: Urologists should consider approaching the topic of infertility when discussing the pros and cons of various prostate cancer therapies with their younger patients.

UR - http://www.scopus.com/inward/record.url?scp=33750362061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750362061&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2006.04.009

DO - 10.1016/j.urology.2006.04.009

M3 - Article

C2 - 17070364

AN - SCOPUS:33750362061

VL - 68

SP - 840

EP - 844

JO - Urology

JF - Urology

SN - 0090-4295

IS - 4

ER -